Diamond Biotechnology Co., Ltd (TPEX:6815)
Taiwan · Delayed Price · Currency is TWD 59.30
0.00 (0.00%)
At close: Feb 11, 2026
Diamond Biotechnology Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 35.17 | 73.2 | 46.74 | 33.39 | 41.92 | 11.05 |
Depreciation & Amortization | 25.46 | 27.8 | 50.1 | 52.96 | 57.59 | 54.26 |
Other Amortization | 0.24 | 0.23 | 0.22 | 0.52 | 0.59 | 0.56 |
Loss (Gain) From Sale of Assets | -1.15 | 4.72 | - | -0.1 | -1.35 | -0.72 |
Loss (Gain) From Sale of Investments | - | - | - | - | -0.03 | - |
Provision & Write-off of Bad Debts | 10.28 | 4.44 | 1.46 | 0.85 | 0.21 | -1.59 |
Other Operating Activities | -10.85 | 8.67 | -4.22 | 3.82 | 8.02 | -3.9 |
Change in Accounts Receivable | 51.34 | -42.74 | -48.9 | 39.49 | -86.78 | 22.5 |
Change in Inventory | -30.25 | -37.29 | -1.92 | 2.2 | -14.01 | -13.02 |
Change in Accounts Payable | -0.29 | 35.57 | -9.81 | 6.23 | 19.45 | -2.03 |
Change in Unearned Revenue | -4.32 | 16.94 | 1.58 | 7.1 | -6.29 | -1.75 |
Change in Other Net Operating Assets | -12.01 | -57.84 | 5.65 | 11.07 | -13.7 | 5.81 |
Operating Cash Flow | 63.62 | 33.7 | 40.9 | 157.53 | 5.65 | 71.17 |
Operating Cash Flow Growth | - | -17.61% | -74.03% | 2690.66% | -92.07% | 207.34% |
Capital Expenditures | -8.2 | -29.26 | -196.62 | -72.96 | -24.9 | -56.38 |
Sale of Property, Plant & Equipment | 2.44 | 28.58 | - | 2.95 | 1.49 | 34.95 |
Sale (Purchase) of Intangibles | -0.93 | -0.93 | - | - | - | -0.59 |
Investment in Securities | -60 | -90 | - | - | - | - |
Other Investing Activities | 12.29 | 9.72 | 0.31 | -62.56 | -28.7 | -4.84 |
Investing Cash Flow | -54.32 | -81.89 | -196.31 | -132.57 | -52.11 | -26.85 |
Short-Term Debt Issued | - | - | - | 64.47 | 35 | 10 |
Long-Term Debt Issued | - | 64.13 | 256.33 | - | 31 | 30 |
Total Debt Issued | 35 | 64.13 | 256.33 | 64.47 | 66 | 40 |
Short-Term Debt Repaid | - | -91.37 | -23.11 | - | - | - |
Long-Term Debt Repaid | - | -61.99 | -95.18 | -38.89 | -29.69 | -49.18 |
Total Debt Repaid | -98.08 | -153.35 | -118.29 | -38.89 | -29.69 | -49.18 |
Net Debt Issued (Repaid) | -63.08 | -89.22 | 138.04 | 25.58 | 36.31 | -9.18 |
Issuance of Common Stock | 0.71 | 221.71 | - | - | - | - |
Repurchase of Common Stock | -16.86 | -1.39 | - | - | - | - |
Common Dividends Paid | -4.95 | -4.95 | -3.02 | -3.81 | -0.99 | -29.28 |
Other Financing Activities | -0.06 | -0.18 | 0.45 | 0.52 | - | - |
Financing Cash Flow | -84.24 | 125.98 | 135.46 | 22.29 | 35.32 | -38.46 |
Foreign Exchange Rate Adjustments | -4.07 | -0.2 | -0.01 | 0.01 | -0 | -0.03 |
Net Cash Flow | -79 | 77.59 | -19.96 | 47.27 | -11.15 | 5.83 |
Free Cash Flow | 55.42 | 4.44 | -155.72 | 84.57 | -19.25 | 14.79 |
Free Cash Flow Growth | - | - | - | - | - | 124.16% |
Free Cash Flow Margin | 7.94% | 0.58% | -25.27% | 19.45% | -4.87% | 4.83% |
Free Cash Flow Per Share | 1.40 | 0.12 | -4.24 | 2.33 | -0.53 | 0.42 |
Cash Interest Paid | 5.64 | 7.44 | 7.52 | 3.74 | 2.27 | 2.48 |
Cash Income Tax Paid | 24.25 | 13.82 | 15.81 | 4.61 | - | 6.15 |
Levered Free Cash Flow | 66 | 1.96 | -173.85 | 72.41 | -31.85 | 7.72 |
Unlevered Free Cash Flow | 69.58 | 6.61 | -169.15 | 74.74 | -30.43 | 9.27 |
Change in Working Capital | 4.47 | -85.35 | -53.4 | 66.09 | -101.32 | 11.51 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.